All Resources
Read all of the latest breakthroughs, insights, and news from Ginkgo.
BlogSeptember 17, 2024
Introducing Ginkgo’s Model API: A Programmable Interface for Ginkgo’s AI ResearchBlogSeptember 17, 2024
Request Free Inference Tokens for Ginkgo's Model APIBlogSeptember 17, 2024
AminoAcid-0 (AA-0): A Protein LLM Trained with 2 Billion Proprietary SequencesBlogApril 11, 2024
Ginkgo Bioworks Previews Today’s Annual Ferment Conference, Announces “Lab Data as a Service”BlogApril 10, 2024
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles OutbreaksBlogApril 4, 2024
Ginkgo Bioworks to Host 5th Annual Ferment ConferenceBlogMarch 18, 2024
Welcome Dr. Mitch Wolfe!BlogFebruary 27, 2024
Ginkgo Biosecurity Launches Doha-Based Pathogen Monitoring Center, CUBE-D, Establishing Middle East Hub for Global Bioradar, at Qatar Free ZonesBlogDecember 19, 2023
FT011 - Hard, Bad, Bitter: Why I'm Hopeful about AI for BiologyBlogNovember 9, 2023
FT006 - Abstraction Layers and the Foundry Era of Biotech R&DBlogOctober 16, 2023
FT000 - About Foundry TheoryBlogSeptember 21, 2021
The End of the Beginning: Ginkgo Goes PublicBlogJune 9, 2021
600,000 Noses Swabbed!BlogMay 14, 2021
Taking Ginkgo Public on NYSE:DNABlogMarch 18, 2021
Why Ginkgo Cares about Genetic PrivacyBlogDecember 8, 2020
Expanding Ginkgo's Platform for Biosecurity and Pandemic ResponsivenessBlogNovember 16, 2020
Webinar: University Leaders on TestingBlogOctober 23, 2020
Our New Seaport Test Center: Expanding Access to COVID-19 Diagnostic Testing in BostonBlogJune 30, 2020
Needle in a Haystack: Looking for Compounds to Treat COVID-19BlogJune 18, 2020
Concentric by Ginkgo: COVID-19 testing at scaleBlogMay 4, 2020
How to Deploy Millions of COVID-19 Tests Per DayBlogApril 17, 2020
Teaming Up to Improve Antibody Therapeutics for COVID-19BlogApril 15, 2020
Supporting COVID-19 mRNA Vaccine Development with ModernaBlogApril 10, 2020
Project Update: COVID-19 DNA Synthesis
